Related Experiment Video
Updated: Mar 27, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Managing drug-resistant organisms in acute care
Kimberly L Nealy1, Delilah J McCarty, J Andrew Woods
1Kimberly L. Nealy is an assistant professor of Pharmacy Practice at Wingate University School of Pharmacy, Wingate, N.C. Delilah J. McCarty is an assistant professor of Pharmacy Practice at Wingate University School of Pharmacy, Wingate, N.C. J. Andrew Woods is an assistant professor of Pharmacy at Wingate University School of Pharmacy, Wingate, N.C.
Abstract:
The purpose of this article is to provide practitioners with therapeutic considerations for infections caused by drug-resistant organisms in the acute care setting. Proper identification of organisms and appropriate use of antibiotics are imperative strategies to help reduce the development and spread of antimicrobial resistance.
More Related Videos
11:15Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
12:03Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Development of Antibiotic Resistance